These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9723331)

  • 1. Ten year experience in orthotopic heart transplantation: single center result.
    Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1915-6. PubMed ID: 9723331
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine-based steroid-free therapy in pediatric heart transplantation: long-term results.
    Livi U; Caforio AL; Gambino A; Tursi V; Milanesi O; Stellin G; Angelini A; Casarotto D
    Transplant Proc; 1998 Aug; 30(5):1975-6. PubMed ID: 9723358
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for early mortality, acute rejection, and factors affecting first-year survival after heart transplantation.
    Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1912-4. PubMed ID: 9723330
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center.
    Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK
    Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565
    [No Abstract]   [Full Text] [Related]  

  • 5. Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
    Gómez-Sánchez MA; Delgado JF; Escribano P; Santos M; Sotelo T; Gil R; Hernández-Afonso J; Ortuño B; Romero F; Sáenz de la Calzada C; Rodriguez JE; Rufilanchas JJ
    Transplant Proc; 1998 Aug; 30(5):1671-2. PubMed ID: 9723237
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience.
    Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO
    Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449
    [No Abstract]   [Full Text] [Related]  

  • 8. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac transplantation in Kraków.
    Dziatkowiak A; Garlicki M; Kapelak B; Sadowski J; Wysocka T; Pfitzner R; Pietrzyk E; Wójcik S; Flis E; Rudziński P; Nessler J; Ciechanowicz E; Kopacz J; Frasik W; Olszewska B; Siwińska J; Gulla B; Zawilińska B
    Ann Transplant; 1996; 1(1):46-50. PubMed ID: 9869938
    [No Abstract]   [Full Text] [Related]  

  • 10. Noninvasive monitoring of rejection therapy based on intramyocardial electrograms after orthotopic heart transplantation.
    Grasser B; Schreier G; Iberer F; Wasler A; Petutschnigg B; Müller H; Prenner G; Hipmair G; Hutten H; Schaldach M; Tscheliessnigg KH
    Transplant Proc; 1996 Dec; 28(6):3276-7. PubMed ID: 8962272
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 12. Sole immunosuppressive maintenance with cyclosporine A after heart transplantation.
    Koerner MM; Tenderich G; Mannebach H; zu Knyphausen E; Koertke H; Kleesiek K; Gleichmann U; Meyer H; Koerfer R
    Transplant Proc; 1996 Dec; 28(6):3119-21. PubMed ID: 8962209
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter evaluation of immunosuppressive regimens in heart transplantation. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1997; 29(1-2):617-9. PubMed ID: 9123156
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney transplantation in pediatric population.
    Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M
    Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
    [No Abstract]   [Full Text] [Related]  

  • 15. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

  • 17. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
    Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
    Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
    [No Abstract]   [Full Text] [Related]  

  • 18. Rabbit antithymocyte globulin induction immunosuppression in heart transplantation.
    Chien NC; Lin FL; Chou NK; Hsu RB; Wang SS; Chu SH; Ko WJ
    Transplant Proc; 2000 Nov; 32(7):2380-2. PubMed ID: 11120209
    [No Abstract]   [Full Text] [Related]  

  • 19. Morbidity, mortality beyond the 10th year following heart transplant: data from a population of 163 patients.
    Sebbag L; Boissonnat P; Obadia JF; Gare JP; Perinetti M; Loire R; Dureau G
    Transplant Proc; 2001; 33(7-8):3551-2. PubMed ID: 11750511
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.